# Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)

> **NCT04734353** · PHASE4 · UNKNOWN · sponsor: **Gyeongsang National University Hospital** · enrollment: 492 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Prasugrel 5mg
- **DRUG:** Ticagrelor 60mg

## Key facts

- **NCT ID:** NCT04734353
- **Lead sponsor:** Gyeongsang National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-15
- **Primary completion:** 2021-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 492 (ESTIMATED)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04734353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04734353, "Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04734353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*